NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018

View More View Less
  • 1 Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Duke Cancer Institute; Yale Cancer Center/Smilow Cancer Hospital; Massachusetts General Hospital Cancer Center; Moffitt Cancer Center; Vanderbilt-Ingram Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Mayo Clinic Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Roswell Park Comprehensive Cancer Center; Huntsman Cancer Institute at the University of Utah; University of Colorado Cancer Center; City of Hope Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Fox Chase Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Washington/Seattle Cancer Care Alliance; University of Wisconsin Carbone Cancer Center; University of Michigan Rogel Cancer Center; Fred & Pamela Buffett Cancer Center; and National Comprehensive Cancer Network.
Restricted access

The NCCN Guidelines for Head and Neck (H&N) Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the H&N, and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding evaluation and treatment of nasopharyngeal carcinoma.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 220 KB)
All Time Past Year Past 30 Days
Abstract Views 5 0 0
Full Text Views 10800 7101 479
PDF Downloads 3206 2066 133
EPUB Downloads 0 0 0